Amicogen (XKRX:092040) Accounts Payable & Accrued Expense : ₩9,245 Mil (As of Mar. 2025)

View and export this data going back to 2013. Start your Free Trial

What is Amicogen Accounts Payable & Accrued Expense?

Amicogen's quarterly accounts payable & accrued expense declined from Sep. 2024 (₩55,804 Mil) to Dec. 2024 (₩15,632 Mil) and declined from Dec. 2024 (₩15,632 Mil) to Mar. 2025 (₩9,245 Mil).

Amicogen's annual accounts payable & accrued expense increased from Dec. 2022 (₩52,430 Mil) to Dec. 2023 (₩60,031 Mil) but then declined from Dec. 2023 (₩60,031 Mil) to Dec. 2024 (₩15,632 Mil).

Amicogen Accounts Payable & Accrued Expense Historical Data

The historical data trend for Amicogen's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amicogen Accounts Payable & Accrued Expense Chart

Amicogen Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

24,936.82

50,763.75

52,429.53

60,031.47

15,631.72

Amicogen Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															56,240.69	57,517.02	55,803.84	15,631.72	9,244.70

Amicogen Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Amicogen Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Amicogen Inc (XKRX:092040) » Definitions » Accounts Payable & Accrued Expense

Traded in Other Exchanges

N/A

Address

1259-64, Dongbu-ro, Gyeongsangnam-do, Jinseong-myeon, KOR, 660-852

Website

http://www.amicogen.com

Amicogen Inc is an industrial biotechnology company operating in Korea. It is engaged in the development, production, and distribution of enzymes, bio-new materials, and healthcare food. The company's product portfolio includes special enzymes, N-acetylglucosamine (NAG), pinitol, D-Chiro-inositol (DCI), collagen peptides (CP), and protein A chromatography resins.

Amicogen Headlines

No Headlines